HEPATITIS B VIRUS CORE ANTIGEN
Recombinantly created Hepatitis B Virus center antigen (HBcAg). This center protein section addresses part of the irresistible virions internal center molecule, which encases the viral genome.
Item DETAILS – HEPATITIS B VIRUS CORE ANTIGEN
Recombinant Hepatitis B infection Core protein created in E. coli.
Contains HBV Core immunodominant district.
Accessible in fluid arrangement and cushioned in 10 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM EDTA, half glycerol.
More prominent than 90% virtue by SDS-PAGE.
Immunoreactive with serum of HBV tainted people.
Foundation
HBV is a wrapped DNA infection with a 3.2-kb covalently shut roundabout DNA, which imitates inside the core of contaminated hepatocytes (Seeger and Mason, 2015). Profoundly, polymerase (P), envelope (pre-S1/pre-S2/S) and X. The pre-center/center quality is answerable for articulation of center protein as well as hepatitis B e antigen (HBeAg), a serological marker of HBV contamination corresponding with high popular burden.
The 5′ finish of pre-S1, pre-S2 and S districts all have autonomous beginning codons which can each produce three co-terminal envelope proteins called enormous (L; pre-S1 pre-S2 S), center (M; pre-S2 S), and little (S; with S area alone) envelope proteins. The S protein is the most plentiful envelope protein communicated and can be discharged freely of L and M envelope proteins. After emission, mature HBeAg is erased at buildup 149 C-terminally and holds 10 pre-center deposits N-terminally. Both L and S envelope proteins are required for virion emission, while M protein is nonessential (Bruss and Ganem, 1991; Ueda et al., 1991).
Human Leucine-rich repeat flightless-interacting protein 1 (LRRFIP1) |
|||
1-CSB-EP013175HU(B) | Cusabio |
|
|
Human Plexin-A1 (PLXNA1) |
|||
1-CSB-RP143094h(B) | Cusabio |
|
|
Hepatitis B Virus antibody |
|||
10-H05K | Fitzgerald | 1 mg | 159.6 EUR |
Hepatitis B Virus antibody |
|||
10-H05M | Fitzgerald | 1 mg | 159.6 EUR |
Hepatitis B Virus antibody |
|||
10R-7754 | Fitzgerald | 500 ug | 638.4 EUR |
Recombinant Hepatitis B Virus x |
|||
7-07420 | CHI Scientific | 5µg | Ask for price |
Recombinant Hepatitis B Virus x |
|||
7-07421 | CHI Scientific | 25µg | Ask for price |
Recombinant Hepatitis B Virus x |
|||
7-07422 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis B Virus HBe |
|||
7-07426 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis B Virus HBe |
|||
7-07427 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis B Virus HBe |
|||
7-07428 | CHI Scientific | 1000µg | Ask for price |
Hepatitis B Virus preS1 antibody |
|||
10-H07A | Fitzgerald | 1 mg | 405.6 EUR |
Hepatitis B Virus preS1 antibody |
|||
10-H07B | Fitzgerald | 1 mg | 405.6 EUR |
Hepatitis B Virus preS2 antibody |
|||
10-H08A | Fitzgerald | 1 mg | 405.6 EUR |
Anti-Hepatitis B Virus Antibody |
|||
A30379 | BosterBio | 100ug/vial | 400.8 EUR |
Hepatitis B Virus (HBV) Antibody |
|||
20-abx137061 | Abbexa |
|
|
Hepatitis B Virus HBe Protein |
|||
20-abx260125 | Abbexa |
|
|
Hepatitis B Virus x Protein |
|||
20-abx262147 | Abbexa |
|
|
Center particles with mature (twofold abandoned DNA) genome can be encompassed and delivered as 42-nm virions, with the three envelope proteins embedded on a superficial level. Void viral particles (22-nm) are additionally bounteously delivered (Bruss and Ganem, 1991; Ganem and Prince, 2004; Zhang and Tang, 2017). HBcAg is one of the three significant clinical antigens of hepatitis B infection yet vanishes from the get-go throughout disease. It is an exceptionally immunogenic subviral molecule including 180 or 240 duplicates of the center protein and capacities as both a T-cell-reliant and a T-cell-free antigen.